Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,563 | -11,654 | -20,063 | -12,720 | -15,010 |
| Depreciation Amortization | 3,487 | 3,153 | 2,739 | 1,770 | N/A |
| Accounts receivable | -382 | -906 | -1,281 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,324 | 388 | 399 | N/A | N/A |
| Other Working Capital | 4,244 | -159 | 2,643 | -13,640 | N/A |
| Other Operating Activity | 800 | 2,507 | 3,608 | -100 | 9,810 |
| Operating Cash Flow | $-2,090 | $-6,671 | $-11,955 | $-24,690 | $-5,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,544 | -2,962 | -918 | -1,540 | N/A |
| Purchase Of Investment | -89 | -170 | N/A | N/A | N/A |
| Other Investing Activity | 28 | 93 | 69 | 100 | 910 |
| Investing Cash Flow | $-1,605 | $-3,039 | $-849 | $-1,440 | $910 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,700 | 13,800 | 21,862 | N/A | N/A |
| Debt Repayment | -4,055 | -4,006 | -9,464 | N/A | N/A |
| Common Stock Issued | 96 | 252 | 49 | N/A | N/A |
| Other Financing Activity | -301 | -425 | -707 | 27,960 | 4,200 |
| Financing Cash Flow | $3,440 | $9,621 | $11,740 | $27,960 | $4,200 |
| Beginning Cash Position | 697 | 786 | 1,850 | 20 | 110 |
| End Cash Position | 442 | 697 | 786 | 1,850 | 20 |
| Net Cash Flow | $-255 | $-89 | $-1,064 | $1,820 | $-90 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,090 | -6,671 | -11,955 | -24,690 | -5,200 |
| Capital Expenditure | -1,544 | -2,962 | -918 | N/A | N/A |
| Free Cash Flow | -3,634 | -9,633 | -12,873 | -24,690 | -5,200 |